Polar Capital’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Polar Capital’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,235,000	Closed	-$15.4M	–	283
2016 Q4	$15.4M	Buy	+1,235,000	New	+$14.9M	0.25%	128

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Polar Capital's ARIA Position: Q1 2017 in Review

Polar Capital sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,235,000 shares — an estimated $15.4M sold.

Polar Capital first reported a position in ARIA in Q4 2016 and held it in 1 quarter. The position peaked at $15.4M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Polar Capital reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Polar Capital sold 1,235,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $15.4M.
Polar Capital first reported a position in Ariad Pharmaceuticals Inc in Q4 2016 and held it in 1 quarter.
Polar Capital's Ariad Pharmaceuticals Inc position peaked at $15.4M in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Polar Capital's 13F filing for Q1 2017, filed 15 May 2017.